Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.7K
3.7K
Nursing Code of Ethics01:29

Nursing Code of Ethics

4.6K
The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.6K
Cancer02:18

Cancer

54.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.3K
What is Cancer?02:12

What is Cancer?

14.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of an instrument to assess public perception of cancer primary prevention information.

Archives of public health = Archives belges de sante publique·2026
Same author

From evidence to action: the IARC's role in strengthening cancer prevention and early detection.

Journal of the National Cancer Institute. Monographs·2026
Same author

60 years of the IARC catalyzing capacity building for cancer prevention.

Journal of the National Cancer Institute. Monographs·2026
Same author

Exploring individual and contextual determinants of cancer prevention behaviour change in the European Union: a qualitative study to inform implementation of the European Code Against Cancer.

The Lancet regional health. Europe·2026
Same author

Cancer Prevention Literacy Questionnaire (CPL-Q): development and validation within the World Code Against Cancer Framework.

BMC public health·2026
Same author

European Code Against Cancer 5th edition: 14 ways you can help prevent cancer.

The Lancet regional health. Europe·2026
Same journal

Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?

Journal of global oncology·2020
Same journal

Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network.

Journal of global oncology·2020
Same journal

Study of the Awareness of Adoption as a Family-Building Option Among Oncofertility Stakeholders in Japan.

Journal of global oncology·2020
Same journal

Building Oncofertility Core Competency in Developing Countries: Experience From Egypt, Tunisia, Brazil, Peru, and Panama.

Journal of global oncology·2020
Same journal

Expanding Coverage of Oncology Drugs in an Aging, Upper-Middle-Income Country: Analyses of Public and Private Expenditures in Chile.

Journal of global oncology·2019
Same journal

Identifying and Prioritizing Family Education Needs at Pediatric Oncology Centers in Central America and Mexico.

Journal of global oncology·2019
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Toward the World Code Against Cancer.

Carolina Espina1, Rolando Herrero1, Rengaswamy Sankaranarayanan1

  • 1Carolina Espina, Rolando Herrero, Rengaswamy Sankaranarayanan, Christopher P. Wild, and Joachim Schüz, International Agency for Research on Cancer, Lyon, France; and Etienne Krug, World Health Organization, Geneva, Switzerland.

Journal of Global Oncology
|September 23, 2018
PubMed
Summary
This summary is machine-generated.

Clear, evidence-based cancer prevention guidelines are needed globally. The European Code Against Cancer offers 12 recommendations, but regional adaptations are necessary for effective worldwide cancer risk reduction.

More Related Videos

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
09:40

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood

Published on: November 28, 2018

7.8K
Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

11.8K

Related Experiment Videos

Last Updated: Feb 5, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K
Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
09:40

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood

Published on: November 28, 2018

7.8K
Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

11.8K

Area of Science:

  • Public Health
  • Cancer Prevention
  • Global Health

Background:

  • Public confusion exists regarding disease prevention messages from diverse media sources.
  • Authoritative, clear, and evidence-based instructions are valued for reducing cancer risk.
  • The European Code Against Cancer provides 12 individual recommendations for cancer risk reduction.

Purpose of the Study:

  • To address the need for globally accessible and effective cancer prevention strategies.
  • To explore the potential for developing regional adaptations of cancer prevention codes.
  • To highlight the limitations of a one-size-fits-all approach to global cancer prevention.

Main Methods:

  • Review of the European Code Against Cancer development and promotion.
  • Analysis of the International Agency for Research on Cancer (IARC) methodology.
  • Consideration of regional differences in cancer risk factors and patterns.

Main Results:

  • The European Code Against Cancer is an authoritative set of recommendations developed by expert scientists.
  • Promoting the European Code has spurred interest in analogous recommendations for other global regions.
  • A simple translation of the European Code is insufficient for global cancer prevention.

Conclusions:

  • Developing a World Code Against Cancer with regional adaptations is feasible using IARC methodology.
  • Regional Codes Against Cancer should be tailored to specific risk factors and cancer patterns.
  • Adapted regional codes are essential for effective global cancer risk reduction.